LRP2 and bladder transitional cell carcinoma: The results showed that in bladder urothelial carcinoma, rectal adenocarcinoma and endometrial carcinoma, patients with LRP2 mutations had significantly higher TMB than those without LRP2 mutations (Fig. S1A).